Comorbidity and survival of Danish lung cancer patients from 2000-2011: A population-based cohort study

Clinical Epidemiology

Volumn 5, Issue SUPP 1, 2013, Pages 31-38

  Deleuran, Thomas ^a   Thomsen, Reimar Wernich ^a   Nørgaard, Mette ^a   Jacobsen, Jacob Bonde ^a   Rasmussen, Torben Riis ^a   Søgaard, Mette ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Comorbidity; Lung cancer; Mortality; Time trends

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CEREBROVASCULAR DISEASE; CHRONIC LUNG DISEASE; COHORT ANALYSIS; COMORBIDITY; CONFIDENCE INTERVAL; CONGESTIVE HEART FAILURE; CONNECTIVE TISSUE DISEASE; DEMENTIA; DENMARK; FEMALE; HEART INFARCTION; HEMATOLOGIC MALIGNANCY; HEMIPLEGIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY DISEASE; LIVER DISEASE; LUNG CANCER; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OVERALL SURVIVAL; PEPTIC ULCER; PERIPHERAL VASCULAR DISEASE; PROPORTIONAL HAZARDS MODEL; SEX DIFFERENCE;

EID: 84887190623     PISSN: None     EISSN: 11791349     Source Type: Journal    
DOI: 10.2147/CLEP.S47473     Document Type: Article

References (31)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893-2917.
2. Nagai K, Yoshida J, Nishimura M. Postoperative mortality in lung cancer patients. Ann Thorac Cardiovasc Surg. 2007;13(6):373-377.
3. Colinet B, Jacot W, Bertrand D, et al. A new simplified comorbidity score as a prognostic factor in non-small-cell lung cancer patients: description and comparison with the Charlson's index. Br J Cancer. 2005;93(10):1098-1105.
4. Crino L, Weder W, van Meerbeeck J, Felip E. Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010;21 Suppl 5:v103-v115.
5. Jørgensen TL, Hallas J, Friis S, Herrstedt J. Comorbidity in elderly cancer patients in relation to overall and cancer-specific mortality. Br J Cancer. 2012;106(7):1353-1360.
6. Deleuran T, Søgaard M, Frøslev T, et al. Completeness of TNM staging of small-cell and non-small-cell lung cancer in the Danish cancer registry, 2004-2009. Clin Epidemio. 2012;(4 Suppl 2):39-44.
7. Young RP, Hopkins RJ, Christmas T, Black PN, Metcalf P, Gamble GD. COPD prevalence is increased in lung cancer, independent of age, sex and smoking history. Eur Respir J. 2009 2009;34(2):380-386.
8. Doll R, Hill AB. The mortality of doctors in relation to their smoking habits: a preliminary report. 1954. BMJ. 2004;328(7455):1529-1533; discussion 1533.
9. Viegi G, Scognamiglio A, Baldacci S, Pistelli F, Carrozzi L. Epidemiology of chronic obstructive pulmonary disease (COPD). Respiration. 2001;68(1):4-19.
10. Janssen-Heijnen ML, Smulders S, Lemmens VE, Smeenk FW, van Geffen HJ, Coebergh JW. Effect of comorbidity on the treatment and prognosis of elderly patients with non-small cell lung cancer. Thorax. 2004;59(7):602-607.
11. Asmis TR, Ding K, Seymour L, et al. Age and comorbidity as independent prognostic factors in the treatment of non small-cell lung cancer: a review of National Cancer Institute of Canada Clinical Trials Group trials. J Clin Oncol. 2008;26(1):54-59.
12. Strand TE, Rostad H, Wentzel-Larsen T, von Plessen C. A population-based evaluation of the seventh edition of the TNM system for lung cancer. Eur Respir J. 2010;36(2):401-407.
13. Blanco JA, Toste IS, Alvarez RF, Cuadrado GR, Gonzalvez AM, Martin IJ. Age, comorbidity, treatment decision and prognosis in lung cancer. Age Ageing. 2008;37(6):715-718.
14. Tammemagi CM, Neslund-Dudas C, Simoff M, Kvale P. Impact of comorbidity on lung cancer survival. Int J Cancer. 2003;103(6): 792-802.
15. Battafarano RJ, Piccirillo JF, Meyers BF, et al. Impact of comorbidity on survival after surgical resection in patients with stage I non-small cell lung cancer. J Thorac Cardiovasc Surg. 2002;123(2):280-287.
16. Vulto AJ, Lemmens VE, Louwman MW, et al. The influence of age and comorbidity on receiving radiotherapy as part of primary treatment for cancer in South Netherlands, 1995 to 2002. Cancer. 2006;106(12):2734-2742.
17. Grønberg BH, Sundstrøm S, Kaasa S, et al. Influence of comorbidity on survival, toxicity and health-related quality of life in patients with advanced non-small-cell lung cancer receiving platinum-doublet chemotherapy. Eur J Cancer. 2010;46(12):2225-2234.
18. Read WL, Tierney RM, Page NC, et al. Differential prognostic impact of comorbidity. J Clin Oncol. 2004;22(15):3099-3103.
19. Danish Health and Medicines Authority. The National Cancer Plan Summary and Recommendations. Copenhagen: National Board of Health; 2005. Available from: http://www.sst.dk/publ/Publ2005/PLAN/kraeftplan2/KraeftplanII_UK/Kraeftplan_II_UK.pdf. Accessed February 5, 2013.
20. Danish Health and Medicines Authority. National Integrated Cancer Pathways. Copenhagen: National Board of Health; 2009. Available from: http://www.sst.dk/English/Cancer_pathways.aspx. Accessed February 5, 2013.
21. National auditrapport januar 2011-december 2011 [Danish]. Copenhagen: Dansk Lunge Cancer Register: 2011. Available from: http://www.lungecancer.dk/documents/00224.pdf. Accessed December 4, 2012.
22. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-383.
23. Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43(11):1130-1139.
24. Brenner H, Rachet B. Hybrid analysis for up-to-date long-term survival rates in cancer registries with delayed recording of incident cases. Eur J Cancer. 2004;40(16):2494-2501.
25. Ramsey SD, Howlader N, Etzioni RD, Donato B. Chemotherapy use, outcomes, and costs for older persons with advanced non-small-cell lung cancer: evidence from surveillance, epidemiology and end results-Medicare. J Clin Oncol. 2004;22(24):4971-4978.
26. D'Addario G, Fruh M, Reck M, Baumann P, Klepetko W, Felip E. Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010;(21 Suppl 5): v116-v119.
27. Søgaard M, Kornum JB, Schønheyder HC, Thomsen RW. Positive predictive value of the ICD-10 hospital diagnosis of pleural empyema in the Danish National Registry of Patients. Clin Epidemiol. 2011;3:85-89.
28. Thomsen RW, Lange P, Hellquist B, et al. Validity and underrecording of diagnosis of COPD in the Danish National Patient Registry. Respir Med. 2011;105(7):1063-1068.
29. Kort-og langtidsoverlevelse efter indlæggelse for udvalgte kræftsygdomme i Nordjyllands, Viborg og Århus amter 1985-2003 [Danish]. Department of Clinical Epidemiology, Aarhus University Hospital. Available from: http://kea.au.dk/files/25.pdf. Accessed 2005.
30. Gjerstorff ML. The Danish Cancer Registry. Scand J Public Health. 2011;39(Suppl 7):42-45.
31. Thygesen SK, Christiansen CF, Christensen S, Lash TL, Sørensen HT. The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients. BMC Med Res Methodol. 2011;11:83.